In order to evaluate whether the modulation of PD-L1 on the tumor cell could be related to a possible adjuvant activity of PD-L1 in vivo, we evaluated the effect of combined therapy of P2Et and αPD-L1 in 4T1 tumor-bearing mice (Figure 2A). Here, CD274 is linked to neoplasm.